Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer

Overview of attention for article published in Journal of Medicinal Chemistry, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 4 X users

patent: 2 patents

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,522 followers.

A team of Ferrier scientists with collaborators @OtagoBiochemist discovered AL-GDa62 as a potent and selective synthetic lethal lead for the treatment of Gastric Cancer. https://t.co/Nl7X251XfS

Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer https://t.co/J9FiNPH0GO

The latest publication from Otago Biochemistry Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer https://t.co/c6lA8hYW3X J Med Chem. 2021 Dec 8. doi: 10.1021/acs.jmedchem.1c01609. Online ahead of print. ABS… …

New article: Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer https://t.co/ntDDckGuW2 #breastcancer #oncology https://t.co/KRrabsHi7G

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.